Results

Total Results: 3,981 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. psnet.ahrq.gov/issue/application-human-factors-analysis-and-classification-system-methodology-cardiovascular
    January 06, 2012 - Application of the human factors analysis and classification system methodology to the cardiovascular … Application of the human factors analysis and classification system methodology to the cardiovascular … Application of the human factors analysis and classification system methodology to the cardiovascular … January 6, 2012 Development and pilot evaluation of a preoperative briefing protocol for cardiovascular
  2. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
    June 02, 2025 - Severe Sepsis and Septic Shock Term Definition Severe sepsis Sepsis plus one of the following: cardiovascular … OR • “Rule out sepsis” OR • “Suspected sepsis” Severe sepsis Sepsis plus one of the following: cardiovascular … syndrome OR two or more other organ dysfunctions. 2 Term Definition Organ dysfunctions Cardiovascular … not applicable for newborn) OR ALT 2 times upper limit of normal for age Septic Shock Sepsis and cardiovascular
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
    October 01, 2009 - Layout 1 Background Nearly 2,400 Americans die of cardiovascular disease each day, an average of one … Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents … Since 1900, cardiovascular disease has accounted for more deaths than any other single cause or group … The TRANSCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular … Composite of High • ACE inhibitor or ARB therapy is better than placebo in cardiovascular mortality,
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
    January 01, 2011 - walking time and distance; improved wound healing; decreased rates of amputation; decreased rates of cardiovascular … Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death) in … Is clopidogrel more effective than aspirin in reducing adverse cardiovascular events in PAD? 3. … )  PAD is a prevalent disease associated with an increased risk of cardiovascular events.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
    January 01, 2010 - response to clopidogrel in patients (1) with acute coronary syndromes, (2) who have suffered other cardiovascular … PICO Population(s): (1) Patients with acute coronary syndrome, (2) patients who have suffered other cardiovascular … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease- related morbidity and … treatment choice for patients who require antiplatelet therapy for the prevention of major adverse cardiovascular … )  While clopidogrel may decrease morbidity and mortality associated with several cardiovascular
  6. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-nyc.pdf
    November 01, 2017 - ensure that primary care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular … and 13 percent Asian).1 Heart disease is the primary cause of death in the city, and prevalence of cardiovascular … Practice Facilitation in a Cluster Randomized Stepped Wedge Design Trial to Improve Adherence to Cardiovascular … Summit, 2016] • Using Practice Facilitation in primary care settings to reduce risk factors for cardiovascular … Conference, 2016] • Using Practice Facilitation in primary care settings to reduce risk factors for cardiovascular
  7. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-6mon-post-intervention-sw.pdf
    April 03, 2017 - Please identify how your practice uses clinical guidelines for cardiovascular disease prevention (for … Reporting measurements of practice performance on cardiovascular disease prevention measures (such as … Setting goals and benchmarking rates of performance quality on cardiovascular disease prevention measures … Customizing the implementation of cardiovascular disease prevention care changes to the practice £ £ … [Check all that apply] ¨ Aspirin use for patients with ASCVD (atherosclerotic cardiovascular disease
  8. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/cholesterol-academic-detailing-guide.pdf
    July 07, 2015 - coronary artery disease1,2 i16% Reduction in absolute risk of death i20% Reduction in all major cardiovascular … events Manage cholesterol aggressively for patients at highest risk of atherosclerotic cardiovascular … C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds … General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/behavioral-counseling-interventions-promote-healthy-diet-physical-activity-weight-loss-prevent-cardiovascular-disease-adults
    November 02, 2023 - progress Final Research Plan Healthy Diet, Physical Activity, and/or Weight Loss to Prevent Cardiovascular … Abbreviations: BP=blood pressure; CVD=cardiovascular … behavioral counseling interventions to promote healthy diet, physical activity, and/or weight loss improve cardiovascular … e.g., nutritional deficiencies, disordered eating, symptoms of anxiety, musculoskeletal injuries, or cardiovascular … Abbreviations: BMI=body mass index; CVD=cardiovascular disease; KQ=key question; USPSTF=U.S.
  10. integrationacademy.ahrq.gov/sites/default/files/2020-07/Ischemic_Vascular_Disease_Blood_Pressure_Control.pdf
    January 01, 2020 - Adjustment: No Classification: National Quality Strategy Priorities: Prevention and Treatment of Cardiovascular … System (PQRS) Actual/Planned Use: Care Setting: Ambulatory Care: Clinician Office/Clinic Condition: Cardiovascular … , Cardiovascular: Ischemic Heart Disease, Coronary Artery Disease Cross-Cutting Area: Data Source:
  11. www.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/virginia.html
    March 01, 2021 - that primary care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular … experiences racial, ethnic, and economic disparities in access to care and effectiveness of care for cardiovascular … research (PCOR) findings (both clinical and organizational) into practice, with an initial focus on cardiovascular … : Association Between Practice Ownership or Affiliation With Baseline Performance on Addressing Cardiovascular … Healthcare Report [NAPCRG, 2017] Joy in practice as an enabling strategy for quality improvement in cardiovascular
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
    January 01, 2010 - ahrq12a_Summary_HBP.qxd In the United States, hypertension is responsible for 35% of all cardiovascular … Results Key Question 1: Does Screening for Hypertension Reduce Cardiovascular Disease and Mortality? … The absolute risk for cardiovascular events, however, varies depending on the presence of other cardiovascular … Blood pressure as a cardiovascular risk factor: prevention and treatment. … How do we best individualize treatment for patients based on their cardiovascular risk profile?
  13. meps.ahrq.gov/data_files/publications/st410/stat410.shtml
    May 01, 2013 - Cardiovascular agents were purchased by 28.3 percent of the population and a little less than one-fourth … five therapeutic classes, followed by metabolic agents ($93), central nervous system agents ($65), and cardiovascular … Therapeutic class cardiovascular agents include calcium channel blockers and diuretics; central nervous … Classification Percentage Metabolic agents 19.4 Central nervous system agents 13.4 Cardiovascular … Classification Percentage Metabolic agents 23.3 Central nervous system agents 30.9 Cardiovascular
  14. meps.ahrq.gov/data_files/publications/st153/stat153.pdf
    December 01, 2006 - billion) in y three-quarters of Medi- eneficiaries age 65 and with a prescribed drug se had a cardiovascular … 74.5 percent) in which was a higher per- ge than any of the other e therapeutic classes of . 4, cardiovascular … (figure 1) In 2004, annual expenses for cardiovascular agents represented a quarter (25.8 percent … expense, of the top five therapeutic classes for Medicare beneficiaries age 65 and older in 2004, cardiovascular … 65 and older, 2004 16.7 10.4 8.1 6.8 5.6 0 10 20 30 Medicare population age 65 and older Cardiovascular
  15. meps.ahrq.gov/data_files/publications/st313/stat313.shtml
    February 01, 2011 - expense among adults for prescription drugs were: metabolic agents, central nervous system agents, cardiovascular … which was more than three times the average expense of the therapeutic class with the lowest average (cardiovascular … The therapeutic class cardiovascular agents includes calcium channel blockers and diuretics; central … prescribed drug expenses Metabolic agents 22.5 Central nervous system agents 15.1 Cardiovascular … prescribed drug expenses Metabolic agents 33.8 Central nervous system agents 46.0 Cardiovascular
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/bF5BNLvASN5r9EnP3VTJPN
    December 01, 2010 - Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease … Advice to reduce dietary salt for prevention of cardiovascular disease. … Diet and exercise are equally effective in reducing risk for cardiovascular disease. … Prevention of cardiovascular risk factor eleva- tions in healthy premenopausal women. … CVD � cardiovascular disease; KQ � key question.
  17. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_Data_Requirements_Statin_CVD_Patient_Facing.xlsx
    January 01, 2024 - SNOMED-CT code) LOINC: 63895-7 (question) SNOMED-CT: 55561003 (qualifier) Myocardial Infarction (MI) (Cardiovascular … 2.16.840.1.113883.3.526.3.403 2.16.840.1.113883.3.464.1003.104.12.1001 Ischemic vascular disease (Cardiovascular … 8 VSs IVD:Single VS 2.16.840.1.113883.3.464.1003.104.12.1003 Coronary Artery Bypass Graft (CABG) (Cardiovascular … of 2 VSs 2.16.840.1.113883.3.3157.2000.1 2.16.840.1.113883.3.3157.2000.2 Carotid Intervention (Cardiovascular … 8 VSs IVD:Single VS 2.16.840.1.113883.3.464.1003.104.12.1003 Coronary Artery Bypass Graft (CABG) (Cardiovascular
  18. cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_Data_Requirements_Healthy_Diet_and_Physical_Activity.xlsx
    January 01, 2024 - 2.16.840.1.113883.3.464.1003.195.12.1003 2.16.840.1.113762.1.4.1032.307 Myocardial Infarction (MI) (Cardiovascular … 2.16.840.1.113883.3.526.3.403 2.16.840.1.113883.3.464.1003.104.12.1001 Ischemic vascular disease (Cardiovascular … 8 VSs IVD:Single VS 2.16.840.1.113883.3.464.1003.104.12.1003 Coronary Artery Bypass Graft (CABG) (Cardiovascular … of 2 VSs 2.16.840.1.113883.3.3157.2000.1 2.16.840.1.113883.3.3157.2000.2 Carotid Intervention (Cardiovascular … or false CVD = Union of 8 VSs Carotid Intervention: Single VS 2.16.840.1.113883.3.117.1.7.1.204 Cardiovascular
  19. www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/enhancing-care-heart-failure-patients.pdf
    June 02, 2025 - Investigator, Associate Director of the Cardiac Rehab Program at Brigham and Women’s Hospital, Division of Cardiovascular … Cardiology Unit at Henry Ford Hospital • Michelle Young, MSN, APN-BC, Adult Nurse Practitioner in the Cardiovascular … Implementation of a Hybrid Cardiac Rehabilitation Program: AN EXPANDING OPPORTUNITY FOR OPTIMIZING CARDIOVASCULAR … CARE Cardiac Rehabilitation in Older Adults Cardiac Rehabilitation in Frail Older Adults With Cardiovascular
  20. meps.ahrq.gov/data_files/publications/st313/stat313.pdf
    February 01, 2011 - expense among adults for prescription drugs were: metabolic agents, central nervous system agents, cardiovascular … was more than three times the average expense of the therapeutic class with the lowest average (cardiovascular … The therapeutic class cardiovascular agents includes calcium channel blockers and diuretics; central … , 2008 22.5 15.1 12.3 8.48.7 0 10 20 30 40 Metabolic agents Central nervous system agents Cardiovascular … 33.8 46.0 41.4 17.7 17.1 0 10 20 30 40 50 Metabolic agents Central nervous system agents Cardiovascular